Prevalence of epilepsy in rural Bolivia

Objective: To carry out a door-to-door survey in rural areas of the Cordillera Province, Santa Cruz Department, Bolivia, to determine the prevalence of neurologic diseases (epilepsy, stroke, parkinsonism, and peripheral neuropathy) in a sample of approximately 10,000 inhabitants. Methods: A team of nondoctor health workers administered a standard screening instrument for neurologic diseases—a slightly modified version of the World Health Organization protocol. All subjects found positive during the screening underwent a neurologic examination. Results: On screening, the authors found 1,130 positive subjects, of whom 1,027 were then investigated by neurologists. On the basis of the definition proposed by the International League Against Epilepsy, we detected 124 epileptic patients (prevalence, 12.3/1,000), 112 of whom had active epilepsy (prevalence, 11.1/1,000) on the prevalence day (November 1, 1994). Peak age-specific prevalence occurred in the 15 to 24-year age group (20.4/1,000). Sex-specific prevalence was higher in women (13.1/1,000) than men (11.4/1,000). Eighty-nine patients (71.8%) underwent a standard EEG recording. Considering both EEG and clinical data, partial seizures were the most common type (53.2%) based on the classification of the International League Against Epilepsy. The mean age at onset was 20.7 years for partial seizures and 13.6 years for generalized seizures. Only 10.5% of patients had received specific treatment for more than 2 months of their life. Conclusion: This report on epilepsy prevalence in Bolivia confirms that epilepsy is a major health problem in rural areas of developing countries.

[1]  G. Gregersen Diabetic amyotrophy--a well-defined syndrome? , 2009, Acta medica Scandinavica.

[2]  K. Gydell,et al.  A rare type of femoral-sciatic neuropathy in diabetes mellitus. , 2009, Acta medica Scandinavica.

[3]  W. Maier,et al.  Diagnostic classification of psychiatric disorders and familial-genetic research , 1999, Dialogues in clinical neuroscience.

[4]  Z. Wszolek,et al.  Reduced expression of the G209A α‐synuclein allele in familial parkinsonism , 1999 .

[5]  J. Jankovic,et al.  Bruxism and cranial-cervical dystonia: is there a relationship? , 1999, Cranio : the journal of craniomandibular practice.

[6]  J. Jankovic,et al.  Comparison of mouse bioassay and immunoprecipitation assay for botulinum toxin antibodies , 1999, Journal of neurology, neurosurgery, and psychiatry.

[7]  M. Daha,et al.  Miller Fisher anti‐GQ1b antibodies: α‐Latrotoxin–like effects on motor end plates , 1999 .

[8]  J W Langston,et al.  Parkinson disease in twins: an etiologic study. , 1999, JAMA.

[9]  S. Saip,et al.  Corticosteroid therapy augments gastroduodenal permeability to sucrose , 1998, American Journal of Gastroenterology.

[10]  J. Jankovic,et al.  Peripherally induced oromandibular dystonia , 1998, Journal of neurology, neurosurgery, and psychiatry.

[11]  P. Schmitz,et al.  The spectrum of antecedent infections in Guillain-Barré syndrome , 1998, Neurology.

[12]  D. Luscombe,et al.  Use of corticosteroids in multiple sclerosis by consultant neurologists in the United Kingdom , 1998, Journal of neurology, neurosurgery, and psychiatry.

[13]  A. Hall,et al.  A Neuroepidemiological Survey in Rural Bolivia: Background and Methods , 1998, Neuroepidemiology.

[14]  P. Coyte,et al.  Cost Analysis of Methylprednisolone Treatment of Multiple Sclerosis Patients , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[15]  C. Marsden,et al.  The α‐synuclein Ala53Thr mutation is not a common cause of familial Parkinson's disease: A study of 230 European cases , 1998 .

[16]  C. Wilson,et al.  Paired pulse suppression and facilitation in human epileptogenic hippocampal formation , 1998, Epilepsy Research.

[17]  J. Olesen,et al.  Double-blind, randomized, placebo-controlled study of oral, high-dose methylprednisolone in attacks of MS , 1998, Neurology.

[18]  N. Kohara,et al.  Muscle afferent block for the treatment of oromandibular dystonia , 1998, Movement disorders : official journal of the Movement Disorder Society.

[19]  Á. Pascual-Leone,et al.  Study and modulation of human cortical excitability with transcranial magnetic stimulation. , 1998, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[20]  B. Peterson,et al.  Course of Tic Severity in Tourette Syndrome: The First Two Decades , 1998, Pediatrics.

[21]  I. Osorio,et al.  Real‐Time Automated Detection and Quantitative Analysis of Seizures and Short‐Term Prediction of Clinical Onset , 1998, Epilepsia.

[22]  F. Fera,et al.  Randomized trial comparing two different high doses of methylprednisolone in MS A clinical and MRI study , 1998, Neurology.

[23]  C. Hartmann,et al.  Electrophysiologic evaluation of a patient with peripheral visual field contraction associated with vigabatrin. , 1998, Archives of ophthalmology.

[24]  M. Robertson,et al.  The prevalence of Tourette syndrome in a mainstream school population , 1998, Developmental medicine and child neurology.

[25]  F. Hsu,et al.  GABAA receptor α4 subunit suppression prevents withdrawal properties of an endogenous steroid , 1998, Nature.

[26]  W Paulus,et al.  Transcranial magnetic stimulation: its current role in epilepsy research , 1998, Epilepsy Research.

[27]  G. Krauss,et al.  Vigabatrin-associated retinal cone system dysfunction , 1998, Neurology.

[28]  M. Farrer,et al.  Low frequency of α‐synuclein mutations in familial Parkinson's disease , 1998, Annals of neurology.

[29]  C. Tanner,et al.  Failure to find the a‐synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease , 1998, Neurology.

[30]  Olaf Riess,et al.  AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease , 1998, Nature Genetics.

[31]  D. Rubinow,et al.  Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. , 1998, The New England journal of medicine.

[32]  J. Nutt,et al.  Analysis of the α-synuclein G209A mutation in familial Parkinson's disease , 1998, The Lancet.

[33]  W. Litchy,et al.  Subacute diabetic proximal neuropathy. , 1997, Mayo Clinic proceedings.

[34]  D. Lachar,et al.  Tourette's syndrome and psychopathology in a child psychiatry setting. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.

[35]  C. Kellner,et al.  Electroconvulsive therapy for treatment of intractable seizures , 1997, Neurology.

[36]  G. Grau,et al.  Tumor necrosis factor production capacity as a potentially useful parameter to monitor disease activity in multiple sclerosis. , 1997, European cytokine network.

[37]  P Jallon,et al.  Epilepsy in Developing Countries , 1997, Epilepsia.

[38]  H. Endtz,et al.  Humoral immune response against Campylobacter jejuni lipopolysaccharides in Guillain-Barré and Miller Fisher syndrome , 1997, Journal of Neuroimmunology.

[39]  Sube Banerjee,et al.  Personality disorder and psychopathology in Tourette's syndrome: A controlled study , 1997, British Journal of Psychiatry.

[40]  A. Marson,et al.  The New Antiepileptic Drugs: A Systematic Review of Their Efficacy and Tolerability , 1997, Epilepsia.

[41]  R S Fisher,et al.  Assessment of vagus nerve stimulation for epilepsy: Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology , 1997, Neurology.

[42]  Robert L. Nussbaum,et al.  Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease , 1997 .

[43]  D. C. Morley,et al.  Managing measles. Size of infecting dose may be important. , 1997 .

[44]  B. Jacobs,et al.  Cytomegalovirus infections and anti-GM2 antibodies in Guillain-Barré syndrome. , 1997, Journal of neurology, neurosurgery, and psychiatry.

[45]  C. Lacroix,et al.  Painful proximal diabetic neuropathy: Inflammatory nerve lesions and spontaneous favorable outcome , 1997, Annals of neurology.

[46]  R. Kurlan Future direction of research in Tourette syndrome. , 1997, Neurologic clinics.

[47]  K. Shannon,et al.  Tongue Protrusion Dystonia: Treatment With Botulinum Toxin , 1997, Southern medical journal.

[48]  M. Hallett,et al.  Depression of motor cortex excitability by low‐frequency transcranial magnetic stimulation , 1997, Neurology.

[49]  G. Koob,et al.  The anxiolytic-like effects of the neurosteroid allopregnanolone: interactions with GABAA receptors , 1997 .

[50]  W. Prodinger,et al.  Differential chemotactic activities of sensory neuropeptides for human peripheral blood mononuclear cells. , 1997, Journal of immunology.

[51]  N. Yuki,et al.  Close association of Guillain–Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α , 1997, Journal of Neuroimmunology.

[52]  M. Bouvy,et al.  Applied Therapeutics: The Clinical Use of Drugs. , 1997, Pharmacy World and Science.

[53]  J. Meulstee,et al.  Electrodiagnostic findings related to anti‐GM1 and anti‐GQ1b antibodies in Guillain‐Barré syndrome , 1997, Muscle & nerve.

[54]  S. Farmer,et al.  Randomised trial of oral and intravenous methylprednisolone in acute relapses of multiple sclerosis , 1997, The Lancet.

[55]  C. Woolley,et al.  Estradiol Increases the Sensitivity of Hippocampal CA1 Pyramidal Cells to NMDA Receptor-Mediated Synaptic Input: Correlation with Dendritic Spine Density , 1997, The Journal of Neuroscience.

[56]  H. Tsuji,et al.  Intracortical facilitation and inhibition after transcranial magnetic stimulation in conscious humans. , 1997, The Journal of physiology.

[57]  D J Burn,et al.  Dopaminergic function in familial Parkinson's disease: A clinical and 18F‐dopa positron emission tomography study , 1997, Annals of neurology.

[58]  T Eke,et al.  Retrospective study of concussive convulsions in elite Australian rules and rugby league footballers: phenomenology, aetiology, and outcome , 1997, BMJ.

[59]  K. Leenders,et al.  Long‐term changes of striatal dopamine D2 Receptors in patients with Parkinson's disease: A study with positron emission tomography and [11C]Raclopride , 1997, Movement disorders : official journal of the Movement Disorder Society.

[60]  A. Kishore,et al.  Presynaptic nigrostriatal function in genetically tested asymptomatic relatives from the pallido-ponto-nigral degeneration family , 1996, Neurology.

[61]  J. Uhm,et al.  Interferon β‐1b decreases the migration of T lymphocytes in vitro: Effects on matrix metalloproteinase‐9 , 1996 .

[62]  E M Reiman,et al.  The application of positron emission tomography to the study of the normal menstrual cycle. , 1996, Human reproduction.

[63]  R. Mattson,et al.  Human brain GABA levels rise rapidly after initiation of vigabatrin therapy , 1996, Neurology.

[64]  N. Yuki,et al.  Antibody to Ga1NAc-GD1a and Ga1NAc-GM1b in Guillain—Barré syndrome subsequent to Campylobacter jejuni enteritis , 1996, Journal of Neuroimmunology.

[65]  M. Robertson,et al.  THE NATIONAL HOSPITAL INTERVIEW SCHEDULE FOR THE ASSESSMENT OF GILLES DE LA TOURETTE SYNDROME , 1996 .

[66]  R. Mostafavi,et al.  Treatment selections of 239 patients with blepharospasm and Meige syndrome over 11 years. , 1996, The British journal of ophthalmology.

[67]  M. Polymeropoulos,et al.  Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23 , 1996, Science.

[68]  W. Neugebauer,et al.  Structure-activity studies of B1 receptor-related peptides. Antagonists. , 1996, Hypertension.

[69]  J. Rothwell,et al.  Interaction between intracortical inhibition and facilitation in human motor cortex. , 1996, The Journal of physiology.

[70]  L. Golbe,et al.  Clinical genetic analysis of Parkinson's disease in the contursi kindred , 1996, Annals of neurology.

[71]  H. Meinardi,et al.  Epilepsy in the Tropics: I. Epidemiology, Socioeconomic Risk Factors, and Etiology , 1996, Epilepsia.

[72]  L. Visser,et al.  Campylobacter jejuni infections and anti‐GM1 antibodies in guillain‐barré syndrome , 1996, Annals of neurology.

[73]  S. Chokroverty,et al.  AAEM case report #13: Diabetic amyotrophy , 1996, Muscle & nerve.

[74]  J. Hess,et al.  The agonist selectivity of a mouse B1 bradykinin receptor differs from human and rabbit B1 receptors. , 1996, Immunopharmacology.

[75]  G. Rosoklija,et al.  Diabetic peripheral neuropathy: A clinicopathologic and immunohistochemical analysis of sural nerve biopsies , 1996, Muscle & nerve.

[76]  R. Hilsden,et al.  Intestinal permeability changes in response to acetylsalicylic acid in relatives of patients with Crohn's disease. , 1996, Gastroenterology.

[77]  D J Brooks,et al.  An [18F]dopa-PET and clinical study of the rate of progression in Parkinson's disease. , 1996, Brain : a journal of neurology.

[78]  J. E. Mendizabal,et al.  Prevalence of Epilepsy in a Rural Community of Guatemala , 1996, Epilepsia.

[79]  J. Donoghue,et al.  Long‐term Depression of Horizontal Connections in Rat Motor Cortex , 1996, The European journal of neuroscience.

[80]  J. Holden,et al.  Reproducibility and discriminating ability of fluorine-18-6-fluoro-L-Dopa PET in Parkinson's disease. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[81]  D. Brann,et al.  Diverse modes of action of progesterone and its metabolites , 1996, The Journal of Steroid Biochemistry and Molecular Biology.

[82]  H Scheich,et al.  LTD and LTP induced by transcranial magnetic stimulation in auditory cortex , 1996, Neuroreport.

[83]  A. Ahluwalia,et al.  Involvement of bradykinin B1 receptors in the polymorphonuclear leukocyte accumulation induced by IL-1 beta in vivo in the mouse. , 1996, Journal of immunology.

[84]  S. Hauser,et al.  Stimulus specificity of matrix metalloproteinase dependence of human T cell migration through a model basement membrane. , 1996, Journal of immunology.

[85]  J. French,et al.  A double-blind, placebo-controlled study of Vigabatrin three g/day in patients with uncontrolled complex partial seizures , 1996, Neurology.

[86]  D J Brooks,et al.  Comparison of Methods for Analysis of Clinical [11C]Raclopride Studies , 1996, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[87]  R. Post,et al.  Quenching: inhibition of development and expression of amygdala kindled seizures with low frequency stimulation. , 1995, Neuroreport.

[88]  D. A. Krendel,et al.  Successful treatment of neuropathies in patients with diabetes mellitus. , 1995, Archives of neurology.

[89]  C. McDougle,et al.  Risperidone treatment of children and adolescents with chronic tic disorders: a preliminary report. , 1995, Journal of the American Academy of Child and Adolescent Psychiatry.

[90]  R. Pfeiffer,et al.  A Greek‐American kindred with autosomal dominant, levodopa‐responsive parkinsonism and anticipation , 1995, Annals of neurology.

[91]  Josep Maria Salanova Grau,et al.  Acute axonal Guillain‐Barré syndrome with IgG antibodies against motor axons following parenteral gangliosides , 1995, Annals of neurology.

[92]  J. Meulstee,et al.  Guillain-Barré syndrome without sensory loss (acute motor neuropathy). A subgroup with specific clinical, electrodiagnostic and laboratory features. Dutch Guillain-Barré Study Group. , 1995, Brain : a journal of neurology.

[93]  S. M. Smith,et al.  Auctioneer's jaw: A case of occupational oromandibular hemidystonia , 1995, Movement disorders : official journal of the Movement Disorder Society.

[94]  P. V. D. Van den Bergh,et al.  Five‐year experience in the treatment of focal movement disorders with low‐dose dysportTM botulinum toxin , 1995, Muscle & nerve.

[95]  F. Marceau Kinin B1 receptors: a review. , 1995, Immunopharmacology.

[96]  W. Litchy,et al.  Variables influencing neuropathic endpoints , 1995, Neurology.

[97]  N. Yuki,et al.  Ganglioside-like epitopes of lipopolysaccharides from Campylobacter jejuni (PEN 19) in three isolates from patients with Guillain-Barré syndrome , 1995, Journal of the Neurological Sciences.

[98]  P. Doorn,et al.  Guillain‐Barré syndrome and chronic inflammatory demyelinating polyneuropathy: Immune mechanisms and update on current therapies , 1995, Annals of neurology.

[99]  R. Kikkawa,et al.  Antibodies against GM1 ganglioside affect K+ and NA+ currents in isolated rat myelinated nerve fibers , 1995, Annals of neurology.

[100]  M. Mullen,et al.  Oromandibular dystonia treated with botulinum toxin: report of case. , 1995, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[101]  T. Owens,et al.  The immunology of multiple sclerosis and its animal model, experimental allergic encephalomyelitis. , 1995, Neurologic clinics.

[102]  R. Silva,et al.  Environmental factors and related fluctuation of symptoms in children and adolescents with Tourette's disorder. , 1995, Journal of child psychology and psychiatry, and allied disciplines.

[103]  A. Broocks,et al.  Tumor necrosis factor‐α messenger RNA expression in patients with relapsing‐remitting multiple sclerosis is associated with disease activity , 1995, Annals of neurology.

[104]  K. Gee,et al.  Neuroactive Steroid Actions at the GABAA Receptor , 1994, Hormones and Behavior.

[105]  M Schulzer,et al.  Longitudinal fluorodopa positron emission tomographic studies of the evolution of idiopathic parkinsonism , 1994, Annals of neurology.

[106]  J. Nutt,et al.  Increased risk of Parkinson's disease in parents and siblings of patients , 1994, Annals of neurology.

[107]  K. Marder,et al.  Clinical characteristics of a family with chromosome 17‐linked disinhibition‐dementia‐ parkinsonism‐amyotrophy complex , 1994, Neurology.

[108]  Muhammad Ishaq Khan,et al.  Epilepsy in Pakistan: A Population‐Based Epidemiologic Study , 1994, Epilepsia.

[109]  A. Antonini,et al.  [11C]raclopride and positron emission tomography in previously untreated patients with Parkinson's disease , 1994, Neurology.

[110]  I. Kanazawa,et al.  N‐acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain‐Barré syndrome , 1994, Annals of neurology.

[111]  Mary M. Robertson,et al.  Annotation: Gilles de la Tourette syndrome--an update. , 1994, Journal of child psychology and psychiatry, and allied disciplines.

[112]  C. Lacroix,et al.  Nerve biopsy findings in different patterns of proximal diabetic neuropathy , 1994, Annals of neurology.

[113]  R. Kuzniecky,et al.  Vagus Nerve Stimulation for Treatment of Partial Seizures: 3. Long‐Term Follow‐Up on First 67 Patients Exiting a Controlled Study , 1994, Epilepsia.

[114]  B. Uthman,et al.  Vagus Nerve Stimulation for Treatment of Partial Seizures: 2. Safety, Side Effects, and Tolerability , 1994 .

[115]  J. Wallace,et al.  A simple, non-invasive marker of gastric damage: sucrose permeability , 1994, The Lancet.

[116]  S. Seshadri,et al.  Botulinum toxin A in blepharospasm and hemifacial spasm. , 1994, The Journal of the Association of Physicians of India.

[117]  R. Lesser,et al.  Electrical Stimulation and Language , 1994, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[118]  D. Cohen,et al.  Evidence Against a Genetic Relationship between Tourette's Syndrome and Anxiety, Depression, Panic and Phobic Disorders , 1994, British Journal of Psychiatry.

[119]  R. Hughes,et al.  Campylobacter jejuni and Guillain‐Barré syndrome , 1994, Annals of neurology.

[120]  D. Bettucci,et al.  Idiopathic Generalized Epilepsy: Magnetic Stimulation of Motor Cortex Time‐Locked and Unlocked to 3–Hz Spike‐and Wave Discharges , 1994, Epilepsia.

[121]  C. Waters,et al.  Autosomal dominant Lewy body parkinsonism in a four‐generation family , 1994, Annals of neurology.

[122]  R. Beck,et al.  The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. , 1993, The New England journal of medicine.

[123]  C. Marsden,et al.  Familial parkinsonism with depression: A clinicopathological study , 1993, Annals of neurology.

[124]  C. Marsden,et al.  Corticocortical inhibition in human motor cortex. , 1993, The Journal of physiology.

[125]  M. Hamida,et al.  Prevalence of Epilepsy in Kelibia, Tunisia , 1993, Epilepsia.

[126]  M. Lawden,et al.  Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[127]  I. Kanazawa,et al.  Serum anti‐GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain‐Barré syndrome , 1993, Neurology.

[128]  Orrin Devinsky,et al.  Electrical and Magnetic Stimulation of the Brain and Spinal Cord , 1993 .

[129]  H. Kimura,et al.  Human positron emission tomographic [18F]Fluorodopa studies correlate with dopamine cell counts and levels , 1993, Annals of neurology.

[130]  P A Low,et al.  Composite autonomic scoring scale for laboratory quantification of generalized autonomic failure. , 1993, Mayo Clinic proceedings.

[131]  P C O'Brien,et al.  Cool, warm, and heat‐pain detection thresholds , 1993, Neurology.

[132]  B. Uthman,et al.  Treatment of epilepsy by stimulation of the vagus nerve , 1993, Neurology.

[133]  Prognosis Guidelines for Epidemiologic Studies on Epilepsy , 1993, Epilepsia.

[134]  M. Bear,et al.  Common forms of synaptic plasticity in the hippocampus and neocortex in vitro. , 1993, Science.

[135]  J. Wallace,et al.  Sucrose: a novel permeability marker for gastroduodenal disease. , 1993, Gastroenterology.

[136]  W. J. Litchy,et al.  The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population‐based cohort , 1993, Neurology.

[137]  S. Kochar,et al.  Meige's syndrome. , 1993, The Journal of the Association of Physicians of India.

[138]  H. Willison,et al.  Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. , 1993, Journal of neurology, neurosurgery, and psychiatry.

[139]  R. Hughes,et al.  Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features. , 1993, The Quarterly journal of medicine.

[140]  G. Mwaluko,et al.  Prevalence and Incidence of Epilepsy in Ulanga, a Rural Tanzanian District: A Community‐Based Study , 1992, Epilepsia.

[141]  K. Nagashima,et al.  Myelin Gangliosides of Human Peripheral Nervous System: An Enrichment of GM1 in the Motor Nerve Myelin Isolated from Cauda Equina , 1992, Journal of neurochemistry.

[142]  A. E. Harding,et al.  Parkinson's disease in twins studied with 18F‐dopa and positron emission tomography , 1992, Neurology.

[143]  R P Lesser,et al.  Placebo‐Controlled Pilot Study of Centromedian Thalamic Stimulation in Treatment of Intractable Seizures , 1992, Epilepsia.

[144]  B. Snow,et al.  Rapidly progressive autosomal dominant parkinsonism and dementia with pallido‐ponto‐nigral degeneration , 1992, Annals of neurology.

[145]  N. Weiland Estradiol selectively regulates agonist binding sites on the N-methyl-D-aspartate receptor complex in the CA1 region of the hippocampus. , 1992, Endocrinology.

[146]  R S Fisher,et al.  Motor and sensory cortex in humans: topography studied with chronic subdural stimulation. , 1992, Neurosurgery.

[147]  R P Lesser,et al.  Localization of sensorimotor cortex: the influence of Sherrington and Cushing on the modern concept. , 1992, Neurosurgery.

[148]  Josemir W Sander,et al.  Epileptic seizures in an Andean region of Ecuador. Incidence and prevalence and regional variation. , 1992, Brain : a journal of neurology.

[149]  M. Bear,et al.  Homosynaptic long-term depression in area CA1 of hippocampus and effects of N-methyl-D-aspartate receptor blockade. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[150]  P. Schmitz,et al.  A randomized trial comparing intravenous immune globulin and plasma exchange in Guillain-Barré syndrome. Dutch Guillain-Barré Study Group. , 1992, The New England journal of medicine.

[151]  M. Duchowny,et al.  A safe and effective paradigm to functionally map the cortex in childhood. , 1992, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[152]  P. Lavados,et al.  A descriptive study of epilepsy in the district of El Salvador, Chile, 1984–1988 , 1992, Acta neurologica Scandinavica.

[153]  S. Staugaitis,et al.  Experimental conduction block induced by serum from a patient with anti‐GM1 antibodies , 1992, Annals of neurology.

[154]  W. Rocca,et al.  Validating screening instruments for neuroepidemiologic surveys: experience in Sicily. Sicilian Neuro-Epidemiologic Study (SNES) Group. , 1992, Journal of clinical epidemiology.

[155]  K. Bhoola,et al.  Bioregulation of kinins: kallikreins, kininogens, and kininases. , 1992, Pharmacological reviews.

[156]  Neil R. Miller,et al.  A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .

[157]  Richard S. J. Frackowiak,et al.  Striatal D2 receptor status in patients with Parkinson's disease, striatonigral degeneration, and progressive supranuclear palsy, measured with 11C‐raclopride and positron emission tomography , 1992, Annals of neurology.

[158]  F. Marceau,et al.  Hypotensive effects of Lys-des-Arg9-bradykinin and metabolically protected agonists of B1 receptors for kinins. , 1991, The Journal of pharmacology and experimental therapeutics.

[159]  J. Mendell,et al.  The Bruns-Garland syndrome (diabetic amyotrophy). Revisited 100 years later. , 1991, Archives of neurology.

[160]  P. Schmitz,et al.  Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndrome , 1991, Muscle & nerve.

[161]  N. Hermanowicz,et al.  Treatment of oromandibular dystonia with botulinum toxin , 1991, The Laryngoscope.

[162]  J. McLean,et al.  Castration alters susceptibility of male rats to specific seizures , 1991, Physiology & Behavior.

[163]  L. Melton,et al.  The Rochester Diabetic Neuropathy Study , 1991, Neurology.

[164]  U. Müller,et al.  The Phenotype of the X‐Linked Dystonia‐Parkinsonism Syndrome An Assessment of 42 Cases in the Philippines , 1991, Medicine.

[165]  J. Jankovic,et al.  Therapeutic uses of botulinum toxin. , 1991, The New England journal of medicine.

[166]  W. Rocca,et al.  Door-to-door prevalence survey of neurological diseases in a Sicilian population. Background and methods. The Sicilian Neuro-Epidemiologic Study (SNES) Group. , 1991, Neuroepidemiology.

[167]  G. Barker,et al.  Idiopathic blepharospasm-oromandibular dystonia syndrome (Meige's syndrome) presenting as chronic temporomandibular joint dislocation. , 1991, The British journal of oral & maxillofacial surgery.

[168]  W. Hickey,et al.  T‐lymphocyte entry into the central nervous system , 1991, Journal of neuroscience research.

[169]  T. Miyatake,et al.  Acute axonal polyneuropathy associated with anti‐GM1 antibodies following Campylobacter enteritis , 1990, Neurology.

[170]  W. Reeves,et al.  Epidemiology of Epilepsy in Guaymi Indians from Bocas del Toro Province, Republic of Panama , 1990, Epilepsia.

[171]  K. Nagashima,et al.  Different Ceramide Compositions of Gangliosides Between Human Motor and Sensory Nerves , 1990, Journal of neurochemistry.

[172]  C D Marsden,et al.  Differing patterns of striatal 18F‐dopa uptake in Parkinson's disease, multiple system atrophy, and progressive supranuclear palsy , 1990, Annals of neurology.

[173]  L. Wilkins Assessment: The clinical usefulness of botulinum toxin‐A in treating neurologic disorders , 1990, Neurology.

[174]  J. Jankovic,et al.  Botulinum toxin treatment of cranial-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemifacial spasm. , 1990, Journal of neurology, neurosurgery, and psychiatry.

[175]  M. Robertson,et al.  Familial Tourette's Syndrome in a Large British Pedigree , 1990, British Journal of Psychiatry.

[176]  J. Leckman,et al.  Perinatal factors in the expression of Tourette's syndrome: an exploratory study. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[177]  K. Kidd,et al.  Segregation and linkage analyses of Tourette's syndrome and related disorders. , 1990, Journal of the American Academy of Child and Adolescent Psychiatry.

[178]  Douglas C. Miller,et al.  A large kindred with autosomal dominant Parkinson's disease , 1990, Annals of neurology.

[179]  C. Patlak,et al.  Nigrostriatal function in humans studied with positron emission tomography , 1989, Annals of neurology.

[180]  M. Bolger,et al.  Anticonvulsant profile of the progesterone metabolite 5α-pregnan-3α-ol-20-one , 1989 .

[181]  H. Wiśniewski,et al.  Nerve regeneration patterns after acute ischemic injury , 1989, Neurology.

[182]  D. Cohen,et al.  The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. , 1989, Journal of the American Academy of Child and Adolescent Psychiatry.

[183]  T. Benstead,et al.  Inner perineurial cell vulnerability in ischemia , 1989, Brain Research.

[184]  M. Velasco,et al.  Epileptiform EEG Activities of the Centromedian Thalamic Nuclei in Patients with Intractable Partial Motor, Complex Partial, and Generalized Seizures , 1989, Epilepsia.

[185]  M. Robertson The Gilles de la Tourette Syndrome: the Current Status , 1989, British Journal of Psychiatry.

[186]  R. Kurlan Difficulties in gene localization for Tourette's syndrome. Clinical aspects. , 1989, Molecular and chemical neuropathology.

[187]  M. Brin,et al.  Botulinum Toxin Injection for the Treatment of Oromandibular Dystonia , 1989, The Annals of otology, rhinology, and laryngology.

[188]  G. Alfieri,et al.  Use of botulinum toxin in Meige's disease. , 1988, Rivista di neurologia.

[189]  J. Kaprio,et al.  Parkinson's disease in a nationwide twin cohort , 1988, Neurology.

[190]  H. Lüders,et al.  Localization of Cortical Function: New Information from Extraoperative Monitoring of Patients with Epilepsy , 1988, Epilepsia.

[191]  J. Sipsey,et al.  Are intravenous corticosteroids required in status asthmaticus? , 1988, JAMA.

[192]  G. McKhann,et al.  Serum antibodies to gangliosides in guillain‐barré syndrome , 1988, Annals of neurology.

[193]  L. Gutmann,et al.  Familial parkinsonism, apathy, weight loss, and central hypoventilation , 1988, Neurology.

[194]  A. Bharucha,et al.  Prevalence of Epilepsy in the Parsi Community of Bombay , 1988, Epilepsia.

[195]  R. Koul,et al.  Prevalence and Pattern of Epilepsy (Lath/Mirgi/Laran) in Rural Kashmir, India , 1988, Epilepsia.

[196]  M. Trimble,et al.  The Psychopathology of the Gilles de la Tourette Syndrome , 1988, British Journal of Psychiatry.

[197]  J. Barabé,et al.  Increased blood concentration of des-Arg9-bradykinin in experimental allergic encephalomyelitis , 1988, Journal of the Neurological Sciences.

[198]  M. Ahern,et al.  Pulse steroid therapy in rheumatoid arthritis: can equivalent doses of oral prednisolone give similar clinical results to intravenous methylprednisolone? , 1988, Annals of the rheumatic diseases.

[199]  J. Ferry,et al.  Relative and Absolute Bioavailability of Prednisone and Prednisolone After Separate Oral and Intravenous Doses , 1988, Journal of clinical pharmacology.

[200]  G. Erenberg,et al.  The natural history of Tourette syndrome: A follow‐up study , 1987, Annals of neurology.

[201]  P. Dyck,et al.  Acute ischemia causes axonal stasis, swelling, attenuation, and secondary demyelination , 1987, Annals of neurology.

[202]  M Velasco,et al.  Electrical Stimulation of the Centromedian Thalamic Nucleus in the Treatment of Convulsive Seizures: A Preliminary Report , 1987, Epilepsia.

[203]  R. Uitti,et al.  Familial Parkinson's Disease: Possible Role of Environmental Factors , 1987, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[204]  B. Osuntokun,et al.  Prevalence of the Epilepsies in Nigerian Africans: A Community‐Based Study , 1987, Epilepsia.

[205]  J Jankovic,et al.  Botulinum A toxin for cranial‐cervical dystonia , 1987, Neurology.

[206]  G. Klem,et al.  Extraoperative Cortical Functional Localization in Patients with Epilepsy , 1987, Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society.

[207]  C. Marsden Parkinson's disease in twins. , 1987, Journal of neurology, neurosurgery, and psychiatry.

[208]  D. Cohen,et al.  Gilles de la Tourette's syndrome and obsessive-compulsive disorder. Evidence supporting a genetic relationship. , 1986, Archives of general psychiatry.

[209]  T. Peters,et al.  Lactulose 51Cr-labelled ethylenediaminetetra-acetate, l-rhamnose and polyethyleneglycol 500 as probe markers for assessment in vivo of human intestinal permeability , 1986 .

[210]  P. Thompson,et al.  Focal dystonia of the jaw and the differential diagnosis of unilateral jaw and masticatory spasm. , 1986, Journal of neurology, neurosurgery, and psychiatry.

[211]  J. Kidd,et al.  Familial Tourette's syndrome , 1986, Neurology.

[212]  R P Lesser,et al.  Cortical Afterdischarge and Functional Response Thresholds: Results of Extraoperative Testing , 1984, Epilepsia.

[213]  W. Bradley,et al.  Painful lumbosacral plexopathy with elevated erythrocyte sedimentation rate: A treatable inflammatory syndrome , 1984, Annals of neurology.

[214]  T. Bäckström,et al.  Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsy , 1984, Acta neurologica Scandinavica.

[215]  D. Cohen,et al.  A new instrument for clinical studies of Tourette's syndrome. , 1984, Journal of the American Academy of Child Psychiatry.

[216]  A. Barbeau,et al.  Familial Subsets in Idiopathic Parkinson’s Disease , 1984, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[217]  D. Gajdusek,et al.  Epilepsy in the Gbawein and Wroughbarh Clan of Grand Bassa County, Liberia: The Endemic Occurrence of 'See-ee' in the Native Population , 1983 .

[218]  C. Elger,et al.  Penicillin-induced epileptic foci in the motor cortex: vertical inhibition. , 1983, Electroencephalography and clinical neurophysiology.

[219]  J. Kurtzke Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[220]  D. Gill,et al.  Acute transient myositis of childhood , 1983, Irish journal of medical science.

[221]  C. Ward,et al.  Parkinson's disease in 65 pairs of twins and in a set of quadruplets , 1983, Neurology.

[222]  J. Jankovic,et al.  Blepharospasm and orofacial‐cervical dystonia: Clinical and pharmacological findings in 100 patients , 1983, Annals of neurology.

[223]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[224]  S. Chokroverty Proximal nerve dysfunction in diabetic proximal amyotrophy. Electrophysiology and electron microscopy. , 1982, Archives of neurology.

[225]  R. Ruff,et al.  Viral studies in benign acute childhood myositis. , 1982, Archives of neurology.

[226]  Thomas Je,et al.  Diabetic polyradiculopathy: clinical and electromyographic findings in 105 patients. , 1981 .

[227]  P. Kellaway,et al.  Proposal for Revised Clinical and Electroencephalographic Classification of Epileptic Seizures , 1981, Epilepsia.

[228]  A. Windebank,et al.  Permanent axotomy, a model of axonal atrophy and secondary segmental demyelination and remyelination , 1981, Annals of neurology.

[229]  G. Parry,et al.  Arachidonate-induced experimental nerve infarction , 1981, Journal of the Neurological Sciences.

[230]  E. Tolosa Clinical features of Meige's disease (idiopathic orofacial dystonia): a report of 17 cases. , 1981, Archives of neurology.

[231]  P. Dyck,et al.  Human diabetic endoneurial sorbitol, fructose, and myo‐inositol related to sural nerve morphometry , 1980, Annals of neurology.

[232]  M. Farrell,et al.  Epidemic influenza myopathy in Cincinnati in 1977. , 1980, The Journal of pediatrics.

[233]  J. Snowdon A comparison of written and postbox forms of the Leyton Obsessional Inventory , 1980, Psychological Medicine.

[234]  H. Kessler,et al.  Acute myopathy associated with influenza A/Texas/1/77 infection. Isolation of virus from a muscle biopsy specimen. , 1980, JAMA.

[235]  A. Hays,et al.  Isolation of influenza virus from muscle in myoglobinuric polymyositis , 1979, Neurology.

[236]  W. H. Bradley The American Academy of Otolaryngology , 1979 .

[237]  P. Dyck,et al.  Introduction of automated systems to evaluate touch‐pressure, vibration, and thermal cutaneous sensation in man , 1978, Annals of neurology.

[238]  D. Prince,et al.  Excitability changes in thalamocortical relay neurons during synchronous discharges in cat neocortex. , 1978, Journal of neurophysiology.

[239]  J. Pirart Diabetes Mellitus and Its Degenerative Complications: A Prospective Study of 4,400 Patients Observed Between 1947 and 1973 , 1978, Diabetes Care.

[240]  E. Arciniegas,et al.  Prevalence of epilepsy in Bogota, Colombia , 1978, Neurology.

[241]  R. Buchta Myositis and influenza. , 1977, Pediatrics.

[242]  J. Giangiacomo,et al.  25-hydroxyvitamin D levels and rickets. , 1977, Pediatrics.

[243]  S. Chokroverty,et al.  The syndrome of diabetic amyotrophy , 1977, Annals of neurology.

[244]  A. Asbury Proximal diabetic neuropathy , 1977, Annals of neurology.

[245]  M. Kashgarian,et al.  Postviral myositis: myxovirus-like structures in affected muscle. , 1977, Annals of internal medicine.

[246]  C. Marsden Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia? , 1976, Journal of neurology, neurosurgery, and psychiatry.

[247]  O. Creutzfeldt,et al.  EEG changes during spontaneous and controlled menstrual cycles and their correlation with psychological performance. , 1976, Electroencephalography and clinical neurophysiology.

[248]  J. Schaller,et al.  Acute myositis associated with influenza B infection. , 1976, Pediatrics.

[249]  I. R. Williams,et al.  Subacute proximal diabetic neuropathy , 1976, Neurology.

[250]  I. Mitchell,et al.  Transient acute myositis in childhood. , 1976, Archives of disease in childhood.

[251]  Joseph F. Williams Annual Review of Pharmacology , 1975 .

[252]  H. Wiśniewski,et al.  Peripheral nerve ischemia Part 1. Experimental model , 1975, Journal of the Neurological Sciences.

[253]  E. Ouellette,et al.  The myositis of influenza. , 1973, Archives of neurology.

[254]  S. Yen,et al.  Serum Androstenedione and Testosterone Levels During the Menstrual Cycle , 1973 .

[255]  P. Dyck,et al.  Necrotizing angiopathic neuropathy. Three-dimensional morphology of fiber degeneration related to sites of occluded vessels. , 1972, Mayo Clinic proceedings.

[256]  P C O'Brien,et al.  Segmental demyelination secondary to axonal degeneration in uremic neuropathy. , 1971, Mayo Clinic proceedings.

[257]  R. Beatty,et al.  Orofacial dyskinesia. A dental dimension. , 1971, JAMA.

[258]  D. Hoefnagel Severe myositis during recovery from influenza. , 1970, Lancet.

[259]  A. Asbury,et al.  Ischemic mononeuropathy and mononeuropathy multiplex in diabetes mellitus. , 1968, The New England journal of medicine.

[260]  H. Kutt,et al.  Intravenous diphenylhydantoin in treatment of acute repetitive seizures. 1968. , 1968, Neurology.

[261]  A. Asbury,et al.  Ischemic mononeuropathy multiplex associated with diabetes mellitus. , 1968, Archives of neurology.

[262]  A. Beck,et al.  An inventory for measuring depression. , 1961, Archives of general psychiatry.

[263]  D. W. Mulder,et al.  Femoral neuropathy , 1960, Neurology.

[264]  H. Spiro,et al.  Clinical and physiologic implications of the steroid-induced peptic ulcer. , 1960, The New England journal of medicine.

[265]  Åke Lundberg Myalgia Cruris Epidemica , 1957, Acta paediatrica.

[266]  R.N.DeJ. Epilepsy and the Functional Anatomy of the Human Brain , 1954, Neurology.

[267]  E D Adrian,et al.  The spread of activity in the cerebral cortex , 1936, The Journal of physiology.

[268]  W. Gowers A Manual of Diseases of the Nervous System , 1888, Atlanta Medical and Surgical Journal (1884).

[269]  M. Daha,et al.  Miller Fisher anti-GQ1b antibodies: alpha-latrotoxin-like effects on motor end plates. , 1999, Annals of neurology.

[270]  C. Norwood Managed care reform--round one. , 1999, Cranio : the journal of craniomandibular practice.

[271]  C. Tanner,et al.  Failure to find the alpha-synuclein gene missense mutation (G209A) in 100 patients with younger onset Parkinson's disease. , 1998, Neurology.

[272]  Letters-17 jan 1998 , 1998 .

[273]  R. L. Moss,et al.  Estrogen: nontranscriptional signaling pathway. , 1997, Recent progress in hormone research.

[274]  R. Cheepsattayakorn,et al.  Anti-E as a cause of hemolytic disease of the newborn. , 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[275]  N. Poungvarin,et al.  Botulinum A toxin treatment for blepharospasm and Meige syndrome: report of 100 patients. , 1997, Journal of the Medical Association of Thailand = Chotmaihet thangphaet.

[276]  S E Ide,et al.  Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. , 1997, Science.

[277]  R. L. Moss,et al.  Nongenomic actions of estrogen in the brain: physiological significance and cellular mechanisms. , 1996, Critical reviews in neurobiology.

[278]  Q. Nguyen,et al.  Bradykinin receptor types and B2 subtypes. , 1994, Life sciences.

[279]  V. Torri,et al.  Double-blind trial of dexamethasone versus methylprednisolone in multiple sclerosis acute relapses. , 1994, European neurology.

[280]  M. Brin,et al.  Oromandibular dystonia: Treatment of 96 patients with botulinum toxin A , 1994 .

[281]  A. Berardelli,et al.  Reliability among neurologists in the severity assessment of blepharospasm and oromandibular dystonia: A multicenter study , 1994, Movement disorders : official journal of the Movement Disorder Society.

[282]  Mark Hallett,et al.  Therapy with botulinum toxin , 1994 .

[283]  G. Román,et al.  Epidemiology of epilepsy in developing countries. , 1993, Bulletin of the World Health Organization.

[284]  L. Sedel,et al.  A REPORT OF 17 CASES , 1993 .

[285]  U Ruotsalainen,et al.  PET study on striatal dopamine D2 receptor changes during the progression of early parkinson's disease , 1993, Movement disorders : official journal of the Movement Disorder Society.

[286]  D. Brooks,et al.  Core assessment program for intracerebral transplantations (CAPIT) , 1992, Movement disorders : official journal of the Movement Disorder Society.

[287]  J. Hall,et al.  Bradykinin receptors: pharmacological properties and biological roles. , 1992, Pharmacology & therapeutics.

[288]  R. Bruun,et al.  The natural history of Tourette syndrome. , 1992, Advances in neurology.

[289]  Bruun Rd,et al.  The natural history of Tourette syndrome , 1992 .

[290]  C. Marsden,et al.  A clinical and genetic study of familial Parkinson's disease , 1991, Movement disorders : official journal of the Movement Disorder Society.

[291]  S. Araki,et al.  [Diabetic amyotrophy]. , 1991, Nihon rinsho. Japanese journal of clinical medicine.

[292]  D. Cornblath,et al.  Assessment of current diagnostic criteria for Guillain‐Barré syndrome , 1990, Annals of neurology.

[293]  S. Hodge,et al.  Twin studies and the genetics of Parkinson's disease—a reappraisal , 1990, Movement disorders : official journal of the Movement Disorder Society.

[294]  I. Check,et al.  Human immunoglobulin G and immunoglobulin G subclasses: biochemical, genetic, and clinical aspects. , 1989, Critical reviews in clinical laboratory sciences.

[295]  K. Obata,et al.  Improved method for large-scale purification of brain gangliosides by Q-sepharose column chromatography. Immunochemical detection of C-series polysialogangliosides in adult bovine brains. , 1988, Journal of chromatography.

[296]  J. Patrinely,et al.  Local side effects of botulinum toxin injections. , 1988, Advances in neurology.

[297]  H. Klawans,et al.  Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). , 1988, Advances in neurology.

[298]  E. Tolosa,et al.  Blepharospasm-oromandibular dystonia syndrome (Meige's syndrome): clinical aspects. , 1988, Advances in neurology.

[299]  S. Fahn,et al.  Analysis of open‐label trials in torsion dystonia using high dosages of anticholinergics and other drugs , 1988, Movement disorders : official journal of the Movement Disorder Society.

[300]  Klawans Hl,et al.  Cholinergic pharmacology of blepharospasm with oromandibular dystonia (Meige's syndrome). , 1988 .

[301]  M. Brin,et al.  Localized injections of botulinum toxin for the treatment of focal dystonia and hemifacial spasm , 1987, Movement disorders : official journal of the Movement Disorder Society.

[302]  Diane C. Tsai Recent Developments in Parkinson's Disease , 1986, The Yale Journal of Biology and Medicine.

[303]  J. Rapoport,et al.  The Leyton Obsessional Inventory--Child Version. , 1985, Psychopharmacology bulletin.

[304]  P. Dyck,et al.  Microsphere embolization of nerve capillaries and fiber degeneration. , 1984, The American journal of pathology.

[305]  R. Yu,et al.  Gangliosides: structure, isolation, and analysis. , 1982, Methods in enzymology.

[306]  S. Hakomori Glycosphingolipids in cellular interaction, differentiation, and oncogenesis. , 1981, Annual review of biochemistry.

[307]  P. Birleson The validity of depressive disorder in childhood and the development of a self-rating scale: a research report. , 1981, Journal of child psychology and psychiatry, and allied disciplines.

[308]  U. Slager Diabetic myelopathy. , 1978, Archives of pathology & laboratory medicine.

[309]  S. Chokroverty,et al.  Bruns-Garland syndrome of diabetic amyotrophy. , 1977, Transactions of the American Neurological Association.

[310]  J. Melby Clinical pharmacology of systemic corticosteroids. , 1977, Annual review of pharmacology and toxicology.

[311]  David R. Cox,et al.  Regression models and life tables (with discussion , 1972 .